• PDF: usually within 24 hours UK time

Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 - BRIC: Brazil, Russia, India, China

  • Publication Date:February 2012
  • Publisher:SlideScript
  • Product Type: Report
  • Pages:24

Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 - BRIC: Brazil, Russia, India, China

SlideScript's Lifecycle Pharma Forecast reports deliver essential therapy area benchmarking data and quantitative market estimates projected across multiple regions and individual countries. Data-rich tables enable rapid understanding of market values, product revenue potential and pricing comparisons over a patentable 20-year period.

Insights and projections facilitate, aid, and validate commercial activities related to pricing and reimbursement, market access, health economics modelling, business development, or licensing.

Benefits of this publication include:

  • Country-specific epidemiology: prevalence and disease populations
  • Retail pricing indices across regions and countries
  • Market forecasts to 2035
  • Price-point forecasts to 2035
  • Leading product revenues to 2012
  • Comparative value-based disease market outlook by region
  • Insight into market dynamics across countries
  • Summative market values across territories and age groups
  • Treatment stratification effects on pricing
  • Revenue projections based on dosing regimens

This report is essential to:

  • Support corporate strategy and planning
  • Determine or explore pricing models, health economics, pricing and reimbursement
  • Validate proprietary data, key assumptions, introducing to target markets
  • Evaluate national/regional pricing strengths and weaknesses
  • Benchmark data against market thresholds
  • i. About SlideScript Pharma
  • 1. BRAZIL
  • 2. CHINA
  • 3. INDIA
  • 4. RUSSIA
  • List of Tables
    • 1. BRAZIL
      • Table 1. Alzheimer's Disease: Brazil - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 2. Alzheimer's Disease: Brazil - Treatment Stratification and Market Forecast (USD$), 2012-2019
      • Table 3. Alzheimer's Disease: Brazil - Market Forecast (USD$), 2012-2035
      • Table 4. Alzheimer's Disease: Brazil - Product Revenue Forecast (USD$) 2012-2035
      • Table 5. Alzheimer's Disease: Brazil - Product Revenue Forecast (USD$) 2012-2035
      • Table 6. Alzheimer's Disease: Brazil - Product Revenue Forecast (USD$) 2012-2035
    • 2. CHINA
      • Table 7. Alzheimer's Disease: China - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 8. Alzheimer's Disease: China - Treatment Stratification and Market Forecast (USD$), 2012-2019
      • Table 9. Alzheimer's Disease: China - Market Forecast (USD$), 2012-2035
      • Table 10. Alzheimer's Disease: China - Product Revenue Forecast (USD$) 2012-2035
      • Table 11. Alzheimer's Disease: China - Product Revenue Forecast (USD$) 2012-2035
      • Table 12. Alzheimer's Disease: China - Product Revenue Forecast (USD$) 2012-2035
    • 3. INDIA
      • Table 13. Alzheimer's Disease: India - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 14. Alzheimer's Disease: India - Treatment Stratification and Market Forecast (USD$), 2012-2019
      • Table 15. Alzheimer's Disease: India - Market Forecast (USD$), 2012-2035
      • Table 16. Alzheimer's Disease: India - Product Revenue Forecast (USD$) 2012-2035
      • Table 17. Alzheimer's Disease: India - Product Revenue Forecast (USD$) 2012-2035
      • Table 18. Alzheimer's Disease: India - Product Revenue Forecast (USD$) 2012-2035
    • 4. RUSSIA
      • Table 19. Alzheimer's Disease: Russia - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 20. Alzheimer's Disease: Russia - Treatment Stratification and Market Forecast (USD$), 2012-2019
      • Table 21. Alzheimer's Disease: Russia - Market Forecast (USD$), 2012-2035
      • Table 22. Alzheimer's Disease: Russia - Product Revenue Forecast (USD$) 2012-2035
      • Table 23. Alzheimer's Disease: Russia - Product Revenue Forecast (USD$) 2012-2035
      • Table 24. Alzheimer's Disease: Russia - Product Revenue Forecast (USD$) 2012-2035
+44 20 8816 8548

Ask a question about Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 - BRIC: Brazil, Russia, India, China

Enter the characters you see in the picture below
Captcha